Beth Israel Deaconess Medical Center

Beth Israel Deaconess Medical Center in Boston provides Spravato through its specialty behavioral health program for treatment-resistant depression. The esketamine clinic works with patients whose depression has not improved enough with standard antidepressant treatment. A referral from a current psychiatrist or psychiatric prescriber is required before evaluation.

Spravato is administered through a specialized outpatient program with clinical supervision. The treatment team coordinates with each patient’s existing psychiatric prescriber and considers other advanced treatments when appropriate.

The program also has access to TMS, ECT, psychotherapy, and medication options through BIDMC. Its Boston service draws patients from Greater Boston and surrounding eastern Massachusetts communities.